World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
44325
World Ranking
8185
National Ranking
4245

Overview

Ann H. Partridge is affiliated with Harvard University in the United States and has a research focus primarily in Medicine and Biochemistry, Genetics and Molecular Biology. Their specialization encompasses Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics, and Public Health, Environmental and Occupational Health.

Their work extensively covers topics related to breast cancer treatment studies, cancer risks and factors, cancer survivorship and care, advanced breast cancer therapies, reproductive biology and fertility, BRCA gene mutations in cancer, and HER2/EGFR in cancer research.

Key recent publications by Ann H. Partridge include the following:

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021, published in 2021 in Annals of Oncology
  • Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, published in 2023 in Annals of Oncology
  • Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer, published in 2021 in The Lancet Oncology
  • ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4), published in 2020 in Annals of Oncology
  • Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer, published in 2023 in New England Journal of Medicine

The frequent co-authors associated with Partridge's work include Kathryn J. Ruddy, Shoshana M. Rosenberg, Eric P. Winer, Virginia F. Borges, and Lisa A. Carey.

Their research has been published in a variety of journals, with prominent venues including:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • UNC Libraries
  • The Breast

Ann H. Partridge's scholarly contributions span across multiple subfields with a strong emphasis on clinical and translational oncology. Their research often addresses both therapeutic strategies and survivorship issues in breast cancer, combining clinical practice guidelines and molecular approaches. This positions them as an active contributor to understanding and managing breast cancer treatment and its wider implications for patient care and fertility considerations.

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients

    Stephanie J. Lee;Leslie R. Schover;Ann H. Partridge;Pasquale Patrizio

  • Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Alison W. Loren;Pamela B. Mangu;Lindsay Nohr Beck;Lawrence Brennan

  • Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.

    Kutluk Oktay;Brittany E. Harvey;Ann H. Partridge;Gwendolyn P. Quinn

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Web-based survey of fertility issues in Young women with breast cancer

    Ann H. Partridge;Shari Gelber;Jeffrey Peppercorn;Ebonie Sampson

  • Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation

    Barbara L. Andersen;Robert J. DeRubeis;Barry S. Berman;Jessie Gruman

  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

    Sara M. Tolaney;William T. Barry;Chau T. Dang;Denise A. Yardley

  • Adherence to Therapy With Oral Antineoplastic Agents

    Ann H. Partridge;Jerry Avorn;Philip S. Wang;Eric P. Winer

  • Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer

    Ann H. Partridge;Philip S. Wang;Eric P. Winer;Jerry Avorn

  • Patient adherence and persistence with oral anticancer treatment

    Kathryn Ruddy;Erica Mayer;Ann Partridge

  • Cancer and fertility preservation: international recommendations from an expert meeting

    Matteo Lambertini;Lucia Del Mastro;Maria M.C. Pescio;Claus Yding Andersen

  • Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

    Ann H. Partridge;Andrea LaFountain;Erica Mayer;Brooke S. Taylor

  • Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

    Halle C F Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle

  • Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

    Hyman B. Muss;Hyman B. Muss;Donald A. Berry;Constance T. Cirrincione;Maria Theodoulou

  • Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer

    Harold J. Burstein;Irene Kuter;Susana M. Campos;Rebecca S. Gelman

  • Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.

    Ann H. Partridge;Harold J. Burstein;Eric P. Winer

  • Biology of breast cancer in young women

    Hatem Hamdy Abdel Azim;Ann A.H. Partridge

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy

    Halle C.F. Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle

Frequent Co-Authors

Eric P. Winer
Eric P. Winer Yale University
Rulla M. Tamimi
Rulla M. Tamimi Cornell University
Virginia F. Borges
Virginia F. Borges University of Colorado Boulder
Harold J. Burstein
Harold J. Burstein Harvard University
Lisa A. Carey
Lisa A. Carey University of North Carolina at Chapel Hill
Sara M. Tolaney
Sara M. Tolaney Harvard University
Antonio C. Wolff
Antonio C. Wolff Johns Hopkins University
Ian E. Krop
Ian E. Krop Harvard University
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Karen M. Emmons
Karen M. Emmons Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn’t limited to traditional medical school routes. Many students consider direct entry nursing programs as an alternative and faster pathway into healthcare. These programs are designed for those with prior bachelor’s degrees or relevant experience, offering flexibility and shorter completion times.

For those more interested in administrative or technology roles, earning a degree in health information management is a strong option. There are several reputable medical billing and coding financial aid programs available online, making this career much more accessible and affordable.

If standardized testing is a concern, consider applying to a nursing school that does not require teas test. This allows you to focus on essential coursework and clinical experience without the pressure of entrance exams.

Leadership roles in healthcare are also in demand. Students interested in overseeing healthcare systems can pursue a health care administration degree online, which provides a flexible learning schedule and accelerated degree paths.

With so many diverse paths and online opportunities, pursuing a healthcare career in the US is more accessible than ever.

Best Scientists Citing Ann H. Partridge

Trending Scientists